NYSE:CO Global Cord Blood (CO) Stock Price, News & Analysis → Your Money is Not Safe (From American Alternative) (Ad) Free CO Stock Alerts $1.25 0.00 (0.00%) (As of 04/19/2024 ET) Add Compare Share Share Today's Range$1.25▼$1.2550-Day Range$1.25▼$2.0052-Week Range$2.03▼$5.50Volume50 shsAverage Volume216,519 shsMarket Capitalization$151.94 millionP/E Ratio1.95Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial Media Get Global Cord Blood alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Global Cord Blood Stock (NYSE:CO)Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.Read More CO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CO Stock News HeadlinesApril 17, 2024 | msn.comNigeria rolls out world's first full shot against meningitis: Here's what you need to knowApril 17, 2024 | finance.yahoo.comBlood Collection Market size worth $ 14.76 Billion, Globally, by 2031 at 5.10% CAGR – Report By Verified Market Research®April 19, 2024 | Altimetry (Ad)Secret Bull Market Starts in This Unusual Sector"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. April 16, 2024 | finance.yahoo.comNMDP BioTherapies Introduces Enhanced Cellular Materials for Allogeneic Cell Therapy DevelopmentApril 15, 2024 | msn.comWHO spokesperson raises concerns over growing threat of mosquito-borne illness: 'Their detection by healthcare systems [is] quite challenging'April 12, 2024 | americanbankingnews.comStockNews.com Begins Coverage on Global Cord Blood (NYSE:CO)April 11, 2024 | finance.yahoo.comGlobal Voice Prosthesis Devices Market Size To Worth USD 2.29 Billion By 2033 | CAGR of 5.51%April 4, 2024 | msn.comMark Ruffalo on the ‘evil’ company that poisoned every person on the planet – then kept it secretApril 19, 2024 | Altimetry (Ad)Secret Bull Market Starts in This Unusual Sector"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. April 3, 2024 | msn.comEXPLAINER: What you need to know about TuberculosisApril 3, 2024 | msn.comSurgical objects were mistakenly left in the bodies of more than 200 Philly-area patients over six years. The error is rare, but it can be catastrophic.April 3, 2024 | msn.comReasons for Poor Performance in Nairobi Children - StudyMarch 28, 2024 | msn.comGaza conflict is creating a traumatised generation of child amputees, warn medicsMarch 28, 2024 | sg.finance.yahoo.comOKX’s Global Compliance Chief Left After Six MonthsMarch 28, 2024 | msn.comPreparing for an allergic reactionMarch 20, 2024 | finance.yahoo.comBiobanking Market Outlook Forecast 2024-2029 - Virtual Biobanks Are Gaining PopularityMarch 18, 2024 | msn.comLondon-bound flight from Bangkok makes emergency landing after passenger's suspected suicide attemptMarch 18, 2024 | finance.yahoo.comCell Cryopreservation Market Forecast 2024-2029: Europe Set to Command Significant Share Amid Increasing Scientific AdvancementsMarch 15, 2024 | msn.comHow Safe Are Covid Vaccines? Here’s What We Know NowMarch 15, 2024 | msn.comICSE Class 10 Biology Question Paper 2023 Solved PDF, Check Important Questions and Answers for Last Minute RevisionMarch 14, 2024 | msn.com'Victorian' disease which killed millions now at worldwide high again - these are the symptomsMarch 13, 2024 | businesswire.comSangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPsMarch 13, 2024 | finance.yahoo.comFetal Monitoring Market revenue to reach USD 15.81 Billion by 2035, says Research NesterMarch 11, 2024 | markets.businessinsider.comBrain Canada Celebrates Brain Health Awareness Month with Boost your Brain Awareness CampaignMarch 9, 2024 | mirror.co.ukDesperate families lives are saved by strangers they've never met - delighted mums speak outFebruary 28, 2024 | msn.com'I wouldn’t be here without it': Baby's umbilical cord donation saved Emma's lifeFebruary 28, 2024 | finance.yahoo.comGlobal Biobanking Market Report 2024: Market Set to Surpass $75 Billion in 2024, Growing Demand for Umbilical Cord Blood BankingSee More Headlines Receive CO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/26/2018Today4/19/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:CO CUSIPN/A CIK1467808 Webwww.globalcordbloodcorp.com Phone(523) 605-8180Fax852-3605-8181Employees1,202Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio1.95 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.24 billion Price / Sales0.12 Cash Flow$0.30 per share Price / Cash Flow4.19 Book Value$6.34 per share Price / Book0.20Miscellaneous Outstanding Shares121,551,000Free FloatN/AMarket Cap$151.94 million OptionableNo Data Beta0.16 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesTing ZhengChairman & Chief Executive OfficerBing Chuen ChenChief Financial Officer & DirectorXin XuChief Technology OfficerRui ArashiyamaCEO-Guangdong & Zhejiang DivisionsKey CompetitorsViemed HealthcareNASDAQ:VMDClearPoint NeuroNASDAQ:CLPTCervoMedNASDAQ:CRVOAchieve Life SciencesNASDAQ:ACHVIncannex HealthcareNASDAQ:IXHLView All Competitors CO Stock Analysis - Frequently Asked Questions How have CO shares performed in 2024? Global Cord Blood's stock was trading at $1.22 on January 1st, 2024. Since then, CO stock has increased by 2.5% and is now trading at $1.25. View the best growth stocks for 2024 here. How were Global Cord Blood's earnings last quarter? Global Cord Blood Co. (NYSE:CO) posted its quarterly earnings results on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter. Is Global Cord Blood a good dividend stock? Global Cord Blood (NYSE:CO) pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 12.50%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for CO. What other stocks do shareholders of Global Cord Blood own? Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL). How do I buy shares of Global Cord Blood? Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:CO) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.